
News|Articles|May 15, 2024
2023 Drug Trend Report - Xevant
Advertisement
To effectively navigate the changing pharmacy landscape and maintain a robust, cost-effective pharmacy benefit, you must understand the forces behind rising drug trend.
What’s driving your costs and what can you do about it?
As a leader in the PBM analytics space, we offer a unique perspective on pivotal trend drivers. Here’s what our comprehensive analysis revealed:
-A surge in utilization rates across specialty and non-specialty drugs, magnified by anti-obesity therapies
-Financial strain imposed by anti-inflammatory biologics and the yet-to-be-fulfilled -promise of biosimilar savings
-Persistent price inflation driving higher costs year over year
Sponsored by
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Prior authorization isn’t shrinking. Its savings are
2
Novo Nordisk launches Awiqli, a once-weekly basal insulin
3
David Chen, Pharm.D., on Kaiser Permanente's biosimilar strategy
4
Once-weekly pemvidutide begins phase 3 trial for MASH
5
















